ANDREW MONTGOMERY – ACCREW INVESTMENT ALLEGED SELLING AWAY  – MAY RECOVER INVESTMENT LOSSES

ANDREW MONTGOMERY – ACCREW INVESTMENT ALLEGED SELLING AWAY.

Call 800-500-4442 if you believe Andrew Montgomery recommended or solicited an investment in Accrew or another private security outside of his brokerage firm.

ANDREW J. MONTGOMERY
CRD#: 5668018

Andrew J. Montgomery, a securities industry professional with registrations that have included LBMZ Securities, Inc. and Zacks Investment Management, Inc., has been the subject of allegations involving an outside business activity and a private securities transaction involving Accrew.

According to FINRA BrokerCheck, his former firms alleged that he participated in an outside business activity and private securities transaction and solicited individuals to invest in private securities without disclosure to or approval from the firms. Montgomery disputes those allegations.

Was Accrew Sold Away From a Brokerage Firm?

Selling away generally refers to a registered representative participating in the sale or recommendation of a private securities transaction that has not been approved by the representative’s brokerage firm.

The allegations concerning Montgomery raise questions about whether investors were solicited to invest in Accrew outside the normal supervision and due-diligence procedures of a broker-dealer.

Investors should determine:

• Did Andrew Montgomery recommend Accrew to you?
• Did he solicit you to purchase an Accrew investment?
• Did you invest in Accrew after speaking with Montgomery?
• Did Montgomery describe Accrew as an investment opportunity?
• Did he provide information about Accrew’s expected growth, profitability or potential returns?
• Did he identify himself as a financial adviser or registered representative when discussing the investment?
• Did you believe the investment was being recommended or approved by his brokerage firm?
• Did you send money directly to Accrew or another entity rather than through your brokerage account?
• Were you provided a private placement document, SAFE, subscription agreement or other investment document?
• Did you understand that the investment was separate from your brokerage account?
• Did you understand that the investment had not been approved by the broker-dealer?

These questions may be particularly important for investors who were existing or former clients of Montgomery.

Accrew Investment Risks

An investment in a private company can involve significant risks that may differ from the risks of publicly traded securities.

Private securities may be difficult or impossible to sell. Investors may have limited liquidity and limited ability to determine the current value of their investment. The investment may also depend upon the company’s ability to raise additional capital, execute its business plan and eventually generate sufficient revenue or profits.

Accrew itself warns prospective investors to review its offering circular and risk factors before investing.

Why Selling Away Can Matter to Investors

When a financial professional recommends or solicits a private investment outside the broker-dealer’s approved product platform, investors may question whether the investment was subjected to the firm’s normal due-diligence, suitability and supervisory procedures.

A private investment can therefore raise questions concerning:

• suitability;
• due diligence;
• disclosure of risks;
• conflicts of interest;
• compensation;
• outside business activities;
• private securities transactions;
• supervision;
• financial adviser conduct; and
• broker-dealer responsibility.

Were You An Accrew Investor?

If Andrew Montgomery recommended Accrew to you, or if you invested in Accrew after receiving an investment recommendation from Montgomery, you may want to determine whether the investment was properly disclosed and approved by the brokerage firm with which he was associated.

Goodman & Nekvasil, P.A. Investigates Selling Away Claims

St. Petersburg, Florida law firm Goodman & Nekvasil, P.A. has a national practice representing investors in claims involving brokers, financial advisers and brokerage firms.

The firm investigates claims involving selling away, private securities transactions, unsuitable investment recommendations, undisclosed conflicts of interest, inadequate due diligence and failure to supervise registered representatives.

If you believe Andrew Montgomery recommended or solicited an Accrew investment to you, Goodman & Nekvasil, P.A. may be able to evaluate whether you have a potential claim for recovery through FINRA arbitration or other legal proceedings.

Goodman & Nekvasil, P.A. is investigating brokers who may have unsuitably recommended investments to their clients.

St. Petersburg, Florida law firm Goodman & Nekvasil, P.A., has a national practice representing victimized investors.  The  firm continues to investigate brokerage firms that placed elderly retirees and other conservative investors in unsuitable investments.

Goodman & Nekvasil, P.A., has filed numerous cases against brokerage firms selling high-risk investments and has recovered more than $600 million dollars on behalf of victimized investors.

We allege in these cases that these investment recommendations were unsuitable for our clients in view of their financial situation, needs and investment objectives.

There is no charge for an evaluation of your case. We handle our cases on a contingency fee basis. This means that unless we recover money for you, we charge no attorney’s fee.

If you incurred losses on your investment and would like your case evaluated by a securities attorney, please contact us.

Some of the information in this blog post was obtained from FINRA on 9/11/26. If you believe this information was reported incorrectly, please contact our firm: 1-800-500-4442.